Old drugs find new target for treating brain tumor

November 21, 2011

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor.

The findings are reported in the online edition of the journal Cancer Research.

Perhaps more importantly, the researchers found that two drugs already being used to treat other forms of cancer effectively prolonged the survival of mice modeling this particular form of GBM. That could be good news for at least some GBM patients. More than 9,000 new cases of the disease are diagnosed each year in the United States and effective treatments are limited. The tumors are aggressive and resistant to current therapies, such as surgery, radiation and chemotherapy. The median survival rate for newly diagnosed GBM patients is just 14 months.

Past studies have identified epidermal growth factor receptor (EGFR) as a common genetically altered gene in GBM, though the cause or causes of the alteration is not known. The research team, led by scientists at the Dana-Farber Cancer Institute in Boston, analyzed the GBM genomic database, ultimately identifying and characterizing an exon 27 deletion mutation within the EGFR carboxyl-terminus domain (CTD). An exon is a segment of a DNA or RNA molecule containing information coding for a protein or peptide sequence.

"The deletion mutant seems to possess a novel mechanism for inducing cellular transformation," said Frank Furnari, PhD, associate professor of medicine at the UC San Diego School of Medicine and an associate investigator at the San Diego branch of the Ludwig Institute for Cancer Research.

The study researchers determined that cellular transformation was induced by the previously unknown EGFR CTD deletion mutant, both in vitro and in vivo, and resulted in GBM in the animals. The researchers then turned to testing a pair of approved drugs that target EGFR: a monoclonal antibody called cetuximab and a small molecule inhibitor called erlotinib.

Cetuximab, marketed under the name Erbitux, is currently approved for use in treating metastatic colorectal cancer and squamous cell carcinoma of the head and neck. Erlotinib, marketed under the name Tarceva, is used to treat lung and pancreatic cancers.

Both drugs were found to effectively impair the tumor-forming abilities of oncogenic EGFR CTD deletion mutants. Cetuximab, in particular, prolonged survival of mice with the deletion mutants when compared to untreated control mice.

However, neither cetuximab nor erlotinib is an unabashed success story. The drugs work by binding to sites on the EGFR protein and inhibiting activation, but they are not effective in all cancer patients and produce some adverse side effects, such as rashes and diarrhea.

But Santosh Kesari, MD, PhD, Director of Neuro-Oncology at UC San Diego Moores Cancer Center and the UCSD Department of Neurosciences, and co-corresponding author of the study, said the new study points to a more selective, effective use of the drugs for some patients with GBM.

"In the past when we treated brain cancer patients with these drugs, the response rate was very small," Kesari said. "What we now show is that the tumors with CTD mutations respond best to these EGFR targeted agents. If we knew this beforehand, we might have been able to select patients most likely to respond to these agents. We are now trying to put together a prospective clinical trial to prove this. We would select only patients with these tumor mutations and treat them. This kind of research gets us closer to identifying genetic subtypes, to doing better biomarker-based clinical trials, and to personalizing treatments in brain cancers."

"This is a great example of personalized medicine in action," said Webster Cavenee, PhD, director of the Ludwig Institute at UC San Diego. "UCSD has made a concerted effort in the past few years to develop a first-class brain tumor research and therapy group that includes adult neuro-oncology, neurosurgery, neuropathology and their pediatric equivalents to join with internationally-renowned brain tumor research. This is making UCSD a destination for the very best in brain tumor management."
###

Co-authors of the study are Jeonghee Cho, Department of Medical Oncology, Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston, MA, Genomic Analysis Center, Samsung Cancer Research Institute, Seoul, Republic of Korea; Sandra Pastorino and Ying S. Chao, Department of Neurosciences, Moores Cancer Center, UC San Diego; Qing Zeng and Xiaoyin Xu, Department of Radiology, Brigham and Women's Hospital, Boston; William Johnson, Dana-Farber Cancer Institute, Center for Cancer Genome Discovery, Boston; Scott Vandenberg, Department of Pathology, UC San Diego; Roel Verhaak, Amit Dutt, Derek Chiang and Yuki Yuza, Department of Medical Oncology, Dana-Farber Cancer Institute and Broad Institute of MIT and Harvard; Andrew Cherniack and Robert C. Onofrio, Broad Institute of MIT and Harvard; Hideo Watanabe and Matthew Meyerson, Department of Medical Oncology, Dana-Farber Cancer Institute, Center for Cancer Genome Discovery and Broad Institute of MIT and Harvard; Jihyun Kwon, Genomic Analysis Center, Samsung Cancer Research Institute.

Funding for this research came, in part, from the National Institutes of Health, the Sontag Foundation Distinguished Scientist Award, James S. McDonnell and the Samsung Cancer Research Institution.

University of California - San Diego

---

---

	100 Questions & Answers About Brain Tumors, Second Edition by Virginia Stark-Vance (Author) Whether you¹re a newly diagnosed brain tumor patient, a survivor, or a friend or relative of either, this book offers help. The Second edition of 100 Questions & Answers About Brain Tumors continues the same doctor-patient collaboration, providing authoritative, practical answers to your questions regarding diagnostic testing, treatment options, clinical trials, and much more. Dr. Stark-Vance and M.L. Dubay discuss the latest brain tumor therapies, including the new anti-angiogenesis drugs and brain tumor vaccines. New illustrations throughout the book, from pathology to PET scans, help the reader gain a clear understanding of how brain tumors differ and why these differences are important in making treatment decisions. 100 Questions & Answers About Brain Tumors, Second Edition is an...
	Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment by Peter Black (Author) Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure: • “What is a Brain Tumor?" provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment. • “Coping with Shock” addresses the emotional...
	Curveball: When Life Throws You a Brain Tumor by Liz Holzemer (Author) Life seemed idyllic for thirty-two-year-old Liz Holzemer. Wife of Major League Baseball pitcher Mark Holzemer, Liz was enjoying a successful career as a journalist when an MRI revealed a baseball-size brain tumor she soon found out was called meningioma. Told with clarity and unwavering humor, this book is an inspirational and informative account of one woman’s battle for her life. It shows how she emerged from this frightening diagnosis and two brain surgeries retaining her remarkable spirit of survival and renewed sense of purpose and hope. With practical information about meningioma and brain surgery, Curveball is a manual for people who face life-altering challenges and is also proof that one need not fight such battles alone.
	Damn The Statistics, I Have a Life to Live!: Coping with a Brain Tumor My Personal Story by Harry Wolf (Author) June 3, 2002 was the day that changed my life forever.  A 43-year-old father of three, whom in oneday went from being a successful senior manager to a man with a braintumor.  I have a glioblastoma multiformegrade IV brain tumor, the most deadly and aggressive type of brain tumor.  This book covers how I have dealt with lifeafter being informed that I have a tumor that only 1-2% survive for 2years.  I share the experiences, thoughts,and events from my first year as a survivor. When I was first diagnosed, I searched for a book that covered thedetails of what could be expected on both a medical and personal level.  I could not find, so I wrote one.  I maintained a detailed journal.  I cover the first surgery, an awakecraniotomy, and the subsequent head infection that led to a second...
	Brain Tumor: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Brain Tumor - Revised Edition - Illustrated by S. Smith by Department of Health and Human Services (Author), National Institutes of Health (Author), National Cancer Institute (Author), S. Smith (Editor), S. Smith (Editor) This Brain Tumor Book is the revised version of the popular original version titled "Brain Tumor Causes, Symptoms, Signs, Diagnosis and Treatments", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Brain Tumor, symptoms, causes, and treatments, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of Brain Tumor. You will learn in this Booklet: The Brain Tumor Grades and Types Risk Factors Symptoms...
	Surviving and Thriving: A Brain Tumor Survivor's Story by Tim B Ward (Author) A Brain Tumor Survivor's Story. Tim B. Ward's book takes you through his story of being diagnosed with a brain tumor at the age of twenty-six. Very real details of his story are presented of near death experiences through treatments and recovery. He must deal with the aftermath of gaining a new diagnosis of partial epilepsy. Tim struggles emotionally as well, questioning faith, and facing constant bitterness and anger. However, ultimately he discovers the gifts that come from an experience like this. He gains purpose and a want for an abundant life. This survival story will inspire anyone facing obstacles in their life.
	Brain Tumors: Leaving the Garden of Eden--A Survival Guide to Diagnosis, Learning the Basics, Getting Organized, and Finding Your Medical Team by Paul M. Zeltzer (Author) A guidebook for the 150,000+ people/ year and families affected by brain tumors. This book will help you learn the basics about diagnosis, getting organized and finding your medical team. Included are chapters on all major types of brain tumors & metastases, glossary, medications, using the Internet to search for information, and getting a second opinion. "Brain Tumors:Leaving the Garden of Eden" is all about improving your odds by gathering information, & assessing your situation: What you need to do; what you need to know; what you can do now!
	Connecting through Compassion: Guidance for Family and Friends of a Brain Cancer Patient by Joni James Aldrich (Author), Neysa Peterson (Author) This book candidly discusses the challenges of living with the personality and behavior changes brain cancer brings, and offers practical tools to make the journey easier. Joni Aldrich and Neysa Peterson have each cared for a spouse with a brain illness. They have combined their insights in this practical, straight-talking guide. Readers will learn: symptoms a brain cancer patient may experience; how to create and maintain a warm, comfortable and safe environment; methods to use if communication becomes an issue; how to deal with changes in personality, behavior, and emotions, including loss of social inhibition skills; how to handle issues related to changes in memory and the resulting confusion; how to work through indifference, sadness, and depression towards some peace; how to cope...
	Brain Tumors: An Encyclopedic Approach, Expert Consult - Online and Print, 3e by Andrew H. Kaye MB BS MD FRACS (Author), Edward R. Laws MD PhD (Author) Meet the increasing need for effective brain tumor management with the highly anticipated revision of Brain Tumors by Drs. Andrew H. Kaye and Edward R. Laws. Over the past decade, enormous advances have been made in both the diagnosis and the surgical and radiotherapeutic management of brain tumors. This new edition guides you through the latest developments in the field, including hot topics like malignant gliomas, functional brain mapping, neurogenetics and the molecular biology of brain tumors, and biologic and gene therapy. You'll also have easy access to the complete contents online, with links to PubMed and a downloadable image library, at www.expertconsult.com.Benefit from the knowledge and experience of Drs. Andrew H. Kaye and Edward R. Laws, globally recognized experts in the...
	My Brain Tumour A detailed account of one womans experience after suddenly being diagnosed with a benign meningioma brain tumor. The symptoms that lead to a diagnosis are nothing more than an irritating, involuntary twitch in the left leg which are self-diagnosed as maybe a trapped nerve in the back. No headaches, no dizziness and certainly no pain. This account reveals the emotional roller coaster that unfolds and the fear experienced by Lynda and her family and friends. Relayed in a day by day diary of events from diagnosis, through surgery to an uplifting successful outcome. The Author supplies further reading and helpful contacts and forums for others who find themselves in the same situation. A proportion of each book sold is donated to Brain Tumour Research.